Cystic Changes in Hepatic Metastases from Gastrointestinal Stromal Tumors (GISTs) Treated with Gleevec (Imatinib Mesylate)
Authors:
- 1 October 2002
- journal article
- clinical trial
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 179 (4) , 1059-1062
Abstract
OBJECTIVE. The purpose of this article is to illustrate the CT findings in patients with hepatic metastases from a gastrointestinal stromal tumor who were treated with STI-571.CONCLUSION. Hepatic metastases from gastrointestinal stromal tumors that respond to treatment with STI-571 can appear as near-cystic components with well-defined borders on contrast-enhanced CT. Most metastases became smaller. These metastases resemble simple cysts, but density measurements may differentiate them from one another.Keywords
This publication has 8 references indexed in Scilit:
- Gastrointestinal stromal tumor workshopHuman Pathology, 2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- CT and MR Imaging of Hepatic MetastasesAmerican Journal of Roentgenology, 2000
- Gastrointestinal stromal tumors: Recent advances in understanding of their biologyHuman Pathology, 1999
- Prognosis of Gastrointestinal Smooth-Muscle (Stromal) TumorsAmerican Journal of Surgical Pathology, 1999
- Hepatic metastases: basic principles and implications for radiologists.Radiology, 1995
- Detection of liver neoplasms: Techniques and outcomesAbdominal Radiology, 1994
- Cystic hepatic neoplasms: complementary roles of CT and sonographyAmerican Journal of Roentgenology, 1981